GLB1 and GM1 gangliosidosis: After 28 days of chronic GLB1 overexpression in GM1 gangliosidosis patient cells, the levels of β-gal activity reach supraphysiological levels corresponding to 355% of β-gal activity detected in fibroblasts from a normal individual (Fig. 7A).